NASDAQ: BCABBioatla Inc Stock Ownership - Who owns Bioatla?
Insider buying vs selling
Have Bioatla Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Eric Sievers | Chief Medical Officer | 2026-05-31 | 134 | $3.93 | $526.62Sell |
| Christian Vasquez | Chief Financial Officer | 2026-05-31 | 82 | $3.93 | $322.26Sell |
| Jay M. Phd Short | Chief Executive Officer | 2026-05-31 | 259 | $3.93 | $1.02kSell |
| Jay M. Phd Short | Chief Executive Officer | 2026-03-12 | 639 | $0.17 | $107.35Sell |
| Eric Sievers | Chief Medical Officer | 2026-03-11 | 360 | $0.17 | $60.84Sell |
| Christian Vasquez | Chief Financial Officer | 2026-03-11 | 175 | $0.17 | $29.58Sell |
| Richard A. Waldron | Former Chief Financial Officer | 2026-02-28 | 2,729 | $0.25 | $674.06Sell |
| Jay M. Phd Short | Chief Executive Officer | 2026-02-28 | 7,728 | $0.25 | $1.91kSell |
| Eric Sievers | Chief Medical Officer | 2026-02-28 | 3,140 | $0.25 | $775.58Sell |
| Christian Vasquez | Chief Financial Officer | 2026-02-28 | 1,802 | $0.25 | $445.09Sell |
BCAB insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when BCAB insiders and whales buy or sell their stock.
BCAB Shareholders
What type of owners hold Bioatla Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Carolyn Anderson Short | 418.11% | 6,927,741 | $25.08M | Insider |
| Acorn Capital Advisors LLC | 326.29% | 5,406,345 | $19.57M | Institution |
| Millennium Management LLC | 166.37% | 2,756,674 | $9.98M | Institution |
| Cormorant Asset Management LP | 138.33% | 2,292,060 | $8.30M | Insider |
| Pfizer Inc | 135.07% | 2,238,090 | $8.10M | Insider |
| Vanguard Capital Management LLC | 99.54% | 1,649,252 | $5.97M | Institution |
| Acadian Asset Management LLC | 74.47% | 1,233,919 | $4.47M | Institution |
| Geode Capital Management LLC | 41.59% | 689,182 | $2.49M | Institution |
| Deutsche Bank Ag | 31.71% | 525,352 | $1.90M | Institution |
| Renaissance Technologies LLC | 30.81% | 510,514 | $1.85M | Institution |
BCAB vs Biotech Stocks
Bioatla Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.